期刊
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
卷 16, 期 5, 页码 529-535出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/10837450.2010.502175
关键词
Simvastatin; enhanced solubility; spherical crystallization; DSC; XRPD; FTIR
资金
- Isfahan University of Medical Sciences [386134]
Simvastatin is a hypocholestrolemic drug that is insoluble in water. Its low water solubility rate limits the pharmacological effects. The aim of this study was to improve the dissolution rate of simvastatin using spherical crystallization method. The drug was dissolved in boiling dichloromethane as the good solvent. This solution was added to 5 degrees C water as the non-solvent. After sedimentation, isopropyl acetate was added as the bridging solvent. At the end the crystals were collected and dried for 12 h in a 50 degrees C oven. The FTIR and DSC results showed no change in the drug after crystallization process. XRPD studies showed the sharp peaks are present in the diffractograms of spherical crystals with minor reduction in height of the peaks. The particle size of spherical aggregates was about 37 mu m and the dissolution efficiency of simvastatin up to 60 min increased to about 2-fold in phosphate buffer solution containing 0.5% sodium dodecyl sulfate (pH 7) using the rotating paddle method. Spherical crystals showed enhanced solubility than untreated powder possibly due to partial conversion to amorphous form. Their dissolution rate at 60 min was still 4-fold of untreated powder when stored at 25 degrees C and 84% relative humidity for one month.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据